June 21 Product: argenxs Vyvgart Hytrulo Indication: Chronic inflammatory demyelinating polyneuropathy Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) have a new treatment option after the FDA greenlit argenxs Vyvgart Hytrulo as the first neonatal Fc receptor (FcRn) blocker for the condition
For a deeper look at how BPC-157 interacts with the gut, see BPC-157 and the Gut: How This Peptide Repairs the Intestinal Lining and Reduces Inflammation
D., Gordish-Dressman, H., Hoffman, E
Following stimuli such as toxic insult, infection, or partial hepatectomy, the liver rapidly restores its optimal mass to maintain normal function
Thakral, S
Bo dziaaj odmiennymi, lecz komplementarnymi mechanizmami w obrbie tej samej tkanki bony luzowej jelita